Back to ACRS

UBS Group AG → ACRS

UBS Group AG ACRS Position History

Aclaris Therapeutics, Inc. • Healthcare

Quarters held
14
Latest value
$97K
Q3 2026
Peak value
$2.4M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$3K
Q3 2025$171K
Q3 2025$26K
Q4 2025$5K
Q4 2025$1.1M
Q4 2025$334
Q1 2026$259
Q1 2026$775K
Q2 2026$4K
Q2 2026$1.3M
Q2 2026$104K
Q3 2026$4K
Q3 2026$2.4M
Q3 2026$97K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$97K18.5K——
Q3 2026$2.4M465.3K——
Q3 2026$4K702——
Q2 2026$104K19.6K——
Q2 2026$1.3M236.7K——
Q2 2026$4K702——
Q1 2026$775K206.7K——
Q1 2026$25969——
Q4 2025$334111——
Q4 2025$1.1M360.8K——
Q4 2025$5K1.6K——
Q3 2025$26K13.7K——
Q3 2025$171K89.8K——
Q3 2025$3K1.6K——

Other funds holding ACRS

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B